Acetaminophen remains the most commonly recommended pain reliever and fever reducer during pregnancy, but a growing body of research has raised questions about whether prenatal exposure carries subtle risks for the developing baby. No major medical organization has told pregnant people to stop using it entirely. Instead, the consensus from obstetric and regulatory bodies supports judicious use at the lowest effective dose for the shortest possible time. The concern isn’t about occasional therapeutic use causing dramatic harm; it’s about whether prolonged or frequent exposure nudges the odds on a range of developmental outcomes, from behavior and cognition to reproductive health.
How Acetaminophen Crosses the Placenta
Acetaminophen passes from maternal blood into fetal circulation quickly and easily. Perfusion studies using human placentas show the drug crosses the placental barrier through passive diffusion, moving from mother to fetus faster than it moves in the opposite direction.1PubMed. Transplacental transport of paracetamol and its phase II metabolites using the ex vivo placenta perfusion model Modeling work confirms that acetaminophen levels in fetal umbilical cord blood end up roughly similar to levels in the mother’s blood.2PubMed Central. Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus In other words, if the drug is in your bloodstream, it’s in the baby’s bloodstream too.
The fetal liver can process acetaminophen to some extent, but it does so much more slowly than an adult liver. Oxidation of the drug by fetal liver tissue runs at roughly one-tenth the adult rate, and while the fetal liver can neutralize the drug through one detoxification pathway (sulfation), it cannot efficiently use another (glucuronidation).3PubMed. Acetaminophen: potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells The fetal liver also produces a small amount of the same reactive metabolite that causes liver damage in adult overdose cases, though modeling suggests the fraction converted to this toxic byproduct is very small under normal doses.2PubMed Central. Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus The concern isn’t that a single dose poisons the fetus. It’s that the fetus sits in a bath of the drug for as long as the mother takes it, with limited ability to clear it independently.
The Neurodevelopmental Concern
The headline-grabbing worry over the past decade has been about ADHD, autism spectrum disorder, and related behavioral and cognitive outcomes. A large body of observational research links prenatal acetaminophen exposure to modestly increased rates of these conditions. A 2018 meta-analysis pooling data from seven cohorts and over 130,000 mother-child pairs found that prenatal exposure was associated with about a 34% higher risk of ADHD and a 19% higher risk of autism.4American Journal of Epidemiology. Prenatal Exposure to Acetaminophen and Risk for Attention Deficit Hyperactivity Disorder and Autistic Spectrum Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Cohort Studies A 2021 consensus statement from researchers across multiple disciplines reported that 26 out of 29 observational studies covering more than 220,000 mother-child pairs found positive associations between prenatal acetaminophen and a range of neurodevelopmental outcomes, including ADHD-related behaviors, autism, language delays, lower IQ, and conduct problems.5Nature Reviews Endocrinology. Paracetamol use during pregnancy — a call for precautionary action
One Danish cohort study found that children whose mothers used acetaminophen during pregnancy without having a fever scored an average of 3.4 points lower on performance IQ compared to children whose mothers used neither the drug nor had a fever.6PubMed. Prenatal Use of Acetaminophen and Child IQ: A Danish Cohort Study Another study found that higher acetaminophen use during the second and third trimesters was linked to smaller vocabulary sizes in children, with each additional reported use during the third trimester associated with a decrease of nearly two words in measured vocabulary.7Pediatric Research. Examining the relationship of acetaminophen use during pregnancy with early language development in children These aren’t massive effect sizes, but across millions of pregnancies, even small shifts in the distribution of cognitive and behavioral outcomes could affect a lot of children.
Why the Evidence Is Genuinely Hard to Interpret
The central problem with all of this research is confounding. Pregnant people who take acetaminophen tend to be taking it for a reason: headaches, back pain, fever, infections. Those underlying conditions might themselves affect fetal development. Fever during pregnancy, for instance, independently raises the risk of neurodevelopmental disorders in offspring by about 24% according to a meta-analysis.8PubMed Central. Fever during pregnancy as a risk factor for neurodevelopmental disorders: results from a systematic review and meta-analysis So if a mother takes acetaminophen to treat a fever, is the later ADHD diagnosis linked to the drug or to the fever? Observational studies struggle to untangle this.
The most powerful tool researchers have for handling unmeasured confounding in this context is sibling comparison. If one child was exposed to prenatal acetaminophen and their sibling was not, you can compare outcomes within the same family, which automatically controls for all the genetic and environmental factors the siblings share. A 2024 study published in JAMA applied exactly this approach to a large Swedish dataset. In standard models, prenatal acetaminophen exposure was associated with small increases in risk for autism, ADHD, and intellectual disability. But when the researchers compared siblings within the same family, those associations vanished entirely. The sibling-controlled hazard ratios for autism and ADHD both fell to 0.98, meaning exposed and unexposed siblings had essentially identical rates.9JAMA. Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability
This result suggests that the associations seen in earlier studies may have been driven by factors shared within families, such as genetics, chronic health conditions, or socioeconomic circumstances, rather than by the drug itself. It doesn’t prove acetaminophen is harmless, but it seriously weakens the case that the drug directly causes autism or ADHD. The earlier meta-analyses, for all their statistical significance, relied on observational data that couldn’t adequately control for this kind of familial confounding.
Dose and Duration Seem to Matter
Even among researchers who are skeptical that occasional acetaminophen use causes meaningful harm, there’s broader agreement that prolonged, frequent use is the real concern. A large Danish cohort study found a clear dose-response pattern: the more weeks a mother used acetaminophen during pregnancy, the higher the risk of ADHD-like behaviors in the child. When use exceeded 20 weeks, the risk of an ADHD diagnosis nearly doubled compared to unexposed children.10JAMA Pediatrics. Acetaminophen Use During Pregnancy, Behavioral Problems, and Hyperkinetic Disorders
A Norwegian sibling-controlled cohort study found a similar pattern. Children exposed to acetaminophen for more than 28 days prenatally showed poorer motor development, more behavioral problems, and higher activity levels compared to their unexposed siblings. Short-term use of less than 28 days also showed effects on motor development, but the effects were smaller.11International Journal of Epidemiology. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study This study is worth noting because it used sibling controls and still found effects at high cumulative exposures, which stands in some tension with the 2024 JAMA sibling study that found no association. The difference may come down to how exposure was defined and measured, or to the specific outcomes examined. The safest interpretation is that occasional use looks very different from daily or near-daily use spanning months.
Biomarker data reinforces the idea that frequency matters for actual exposure levels. A study measuring acetaminophen metabolites in maternal urine and cord blood found that all 30 maternal urine samples tested positive for the drug, confirming just how common exposure is. Among women who used it frequently in the third trimester, metabolite levels were significantly higher in both urine and cord blood compared to non-users. By contrast, frequent first-trimester users had metabolite levels similar to non-users, suggesting the body clears the drug between exposures when use isn’t sustained through late pregnancy.12Dove Medical Press. Acetaminophen Use in Pregnancy: A Comparison of Self-Reported Intake with Maternal and Newborn Biomarker Measures
Effects on Reproductive Development
Beyond the brain, acetaminophen has also been linked to effects on the developing reproductive system, and this line of evidence comes from both human epidemiology and animal and tissue experiments. A Danish-Finnish cohort study found that boys whose mothers used acetaminophen during both the first and second trimesters had a roughly 33% increased risk of cryptorchidism, a condition where one or both testicles fail to descend properly. The risk was highest when exposure overlapped with the critical window for testicular descent, between gestational weeks 8 and 14.13PubMed. Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism
On the female side, laboratory studies using human fetal ovarian tissue have shown that acetaminophen can reduce cell numbers, trigger cell death, and disrupt steroid hormone production in first-trimester ovaries.14The Journal of Clinical Endocrinology & Metabolism. Acetaminophen (APAP, Paracetamol) Interferes With the First Trimester Human Fetal Ovary Development in an Ex Vivo Model A mouse study found that in utero exposure to acetaminophen (combined with ibuprofen) during the period of sex determination led to delayed development of egg cells, reduced follicle activation after birth, and even affected fertility in the next generation of female mice.15Communications Biology. In utero exposure to acetaminophen and ibuprofen leads to intergenerational accelerated reproductive aging in female mice Mouse reproductive biology doesn’t map directly onto human biology, but the finding that effects could carry across generations is the kind of signal that keeps researchers interested.
Acetaminophen is known to suppress prostaglandin synthesis, which is the same mechanism that makes NSAIDs like ibuprofen problematic in pregnancy. Prostaglandins play important roles in reproductive organ development, so it’s biologically plausible that a drug interfering with their production during sensitive windows could affect how those organs form.
Respiratory Outcomes and Asthma
A separate line of research has examined whether prenatal acetaminophen exposure increases the risk of childhood asthma and wheezing. A population-based cohort study in Los Angeles found that children born to mothers who used acetaminophen at any point during pregnancy had a 25 to 39% higher risk of developing asthma symptoms, wheezing, or chronic dry cough compared to unexposed children.16PubMed Central. Prenatal Exposure to Acetaminophen and Childhood Asthmatic Symptoms in a Population-Based Cohort in Los Angeles, California The proposed mechanism involves oxidative stress and disruption of antioxidant pathways in the developing lungs. Like the neurodevelopmental data, these are observational findings subject to the same confounding challenges: mothers who take acetaminophen may also have respiratory infections or other inflammatory conditions that independently raise a child’s asthma risk.
Epigenetic Fingerprints
One way researchers are trying to move beyond the limitations of observational studies is by looking for molecular evidence that acetaminophen actually changes something in fetal tissue. A study of extremely preterm newborns found 42 locations in placental DNA where chemical modifications (methylation marks that help regulate gene activity) differed between acetaminophen-exposed and unexposed pregnancies. Two of those sites reached the strictest level of statistical significance, including one in a gene involved in brain development (PPP1R9A).17PubMed Central. Acetaminophen use during pregnancy and DNA methylation in the placenta of the extremely low gestational age newborn (ELGAN) cohort Most of the affected sites showed increased methylation, which generally means reduced activity of the associated genes. This is a single study in a very specific population (extremely preterm infants), so it’s far from proof that acetaminophen rewires fetal gene activity at a meaningful scale. But it provides a plausible molecular pathway that could help explain how a seemingly mild drug might leave lasting marks on development.
Co-Exposures and Combined Effects
Pregnancy doesn’t happen in a chemical vacuum. The question of whether acetaminophen interacts with other common environmental exposures has begun to attract attention. Phthalates, a group of chemicals found in plastics, personal care products, and food packaging, share some anti-androgenic properties with acetaminophen. Research has explored whether the two could have cumulative effects on neurodevelopmental outcomes when exposure overlaps during pregnancy.18IDEALS. Evaluating the relationship between prenatal exposure to acetaminophen and phthalates and early attention and language development This area of research is preliminary, but it’s worth keeping in mind that the real question may not be “is acetaminophen alone harmful?” but rather “what happens when acetaminophen exposure stacks on top of the dozens of other endocrine-active chemicals a fetus encounters?”
What the Guidelines Actually Recommend
Despite the volume of research raising flags, no major medical organization has pulled its endorsement of acetaminophen in pregnancy. A 2025 review in the American Journal of Obstetrics and Gynecology MFM concluded that the current evidence supports continued use of acetaminophen as the preferred pain reliever and fever reducer during pregnancy, used judiciously.19American Journal of Obstetrics & Gynecology MFM. Safety of acetaminophen use in pregnancy: review of existing evidence The Royal College of Obstetricians and Gynaecologists has similarly affirmed its safety while recommending avoidance of NSAIDs like ibuprofen unless specifically directed by a doctor.20Human Reproduction Update. Over-the-counter analgesics during pregnancy: a comprehensive review of global prevalence and offspring safety
The practical guidance that emerges from researchers who have reviewed this evidence is straightforward: use the lowest dose that works, for the shortest time you need it, and talk to your provider about whether you actually need it for a given symptom.5Nature Reviews Endocrinology. Paracetamol use during pregnancy — a call for precautionary action 21Obstetrics & Gynecology Science. Acetaminophen use in pregnancy and autism: separating controversy from scientific evidence This isn’t a dramatic change from general advice about any medication during pregnancy. The difference is that acetaminophen has long been treated as essentially risk-free, and the current evidence suggests that framing deserves some nuance, especially for women who find themselves reaching for it daily over weeks or months.
The alternatives aren’t great, which is part of why acetaminophen keeps its preferred status. NSAIDs like ibuprofen and aspirin carry their own risks during pregnancy, including premature closure of a fetal blood vessel called the ductus arteriosus and potential kidney problems in the fetus, particularly in later pregnancy. For many pregnant people dealing with chronic pain or repeated fevers, there simply isn’t a clearly safer pharmacological option. That reality shapes the clinical recommendation: not “avoid it,” but “don’t treat it as candy.”
Why Self-Reported Use Is Unreliable
One underappreciated problem in this entire field is that most studies rely on mothers remembering and reporting their acetaminophen use, sometimes years after the pregnancy. People underestimate how often they take over-the-counter medications, and acetaminophen hides in hundreds of combination products, from cold remedies to sleep aids, that many users don’t realize contain it. The biomarker study mentioned earlier found acetaminophen metabolites in 100% of maternal urine samples tested, including among women classified as non-users based on self-report.12Dove Medical Press. Acetaminophen Use in Pregnancy: A Comparison of Self-Reported Intake with Maternal and Newborn Biomarker Measures If the “unexposed” group in studies is actually lightly exposed, the true difference between groups would be smaller than reported, and estimated risks would be diluted. This measurement problem cuts both ways: it means the associations found in studies could be underestimates of the true effect, but it also means the “unexposed” comparison group was never truly unexposed, making the whole exercise muddier than it appears.